SPONSOR
St. Jude Children's Research Hospital
Total Trials
16
Recruiting
16
Phases
Phase 1, Phase 2
Conditions studied: Sickle Cell DiseaseCancerFluid OverloadExecutive DysfunctionCognitive ImpairmentAttention Deficit/Hyperactivity Disorder (ADHD)Acute LeukemiaAdenomatous PolyposisAdrenocortical CarcinomaAML
St. Jude Children's Research Hospital is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Sickle Cell Disease, Cancer, Fluid Overload, Executive Dysfunction.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — St. Jude Children's Research Hospital
How many clinical trials has St. Jude Children's Research Hospital sponsored?
ClinicalMetric currently tracks 16 clinical trials sponsored by St. Jude Children's Research Hospital, of which 16 are actively recruiting participants. These trials cover conditions including Sickle Cell Disease, Cancer, Fluid Overload. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does St. Jude Children's Research Hospital research focus on?
St. Jude Children's Research Hospital clinical trials span Sickle Cell Disease, Cancer, Fluid Overload, Executive Dysfunction, Cognitive Impairment, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a St. Jude Children's Research Hospital clinical trial?
To participate in a St. Jude Children's Research Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all St. Jude Children's Research Hospital trials with current recruitment status updated daily.
Clinical Trials by St. Jude Children's Research Hospital
NCT07392216
Recruiting
Functional Ovarian Reserve in Sickle Cell Disease
Sickle Cell Disease
NCT00760656
Recruiting
Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
Cancer
NCT07834710
Recruiting
Using Bioimpedance Analysis to Monitor Fluid Status in Children
Fluid Overload
NCT07226219 Phase 1
Recruiting
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Sickle Cell Disease
NCT03050268
Recruiting
Familial Investigations of Childhood Cancer Predisposition
Acute Leukemia
NCT05955261 Phase 2
Recruiting
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
Acute Myeloid Leukemia
NCT06477289
Recruiting
Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease
Sickle Cell Disease
NCT05664126 Phase 2
Recruiting
Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation
Cytomegalovirus
NCT00684580
Recruiting
Protocol For Collecting Data On Patients With Childhood Cancer
Childhood Cancer
NCT07675083
Recruiting
Bereaved Parent Conversations on Hope
Hope
NCT06506461 Phase 1
Recruiting
Gene Editing For Sickle Cell Disease
Sickle Cell Disease
NCT02530658
Recruiting
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Solid, Liquid, Central Nervous System Tumors
NCT00730678
Recruiting
Pharmacogenetic Determinants Of Treatment Response In Children
All Malignancies
NCT06442761 Phase 1
Recruiting
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Sickle Cell Disease
NCT07314736
Recruiting
Stakeholders of Rare Diseases Informing Values In Neuroethics
Rare Disorder
NCT06023641 Phase 2
Recruiting
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
Rhabdomyosarcoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology